Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO02465)
Xenobiotics Name
BMAP-28
Xenobiotics Type
Amino Acid(s), Peptide(s) or Protein(s)
Classification
Peptide
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=16131512"></iframe>
3D MOL 2D MOL
PubChem CID
16131512
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Azoreductase (azoR) DME Info Enterococcus faecalis [1]
Unclear metabolic mechanism (DME-unclear) DME Info Enterococcus faecalis [1]
D-Lactate dehydrogenase (ldhA) DME Info Pseudomonas aeruginosa [2]
Arylamine N-acetyltransferase (NAT) DME Info Pseudomonas aeruginosa [2]
NADPH-dependent oxidoreductase (nfrA) DME Info Staphylococcus aureus [3]
Hydroxybenzoate 3-monooxygenase (pobA) DME Info Pseudomonas aeruginosa [2]
Tyrosine decarboxylase (tdc) DME Info Enterococcus faecalis [1]
VanA ligase (vanA) DME Info Enterococcus faecalis [1]
VanB ligase (vanB) DME Info Enterococcus faecalis [1]
References
1 BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection. Peptides. 2008 Jul;29(7):1118-23.
2 Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011 Sep;32(9):1807-14.
3 Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides. 2006 Sep;27(9):2104-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.